FDA Inspection 1046035 — The Mount Sinai Hospital
The FDA completed an inspection of The Mount Sinai Hospital on January 24, 2018 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 24, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New York, NY (United States)